Trends in Research on Gantenerumab for Alzheimer’s Disease: A Bibliometric and Thematic Analysis
GR-related literature showed sustained thematic focus, growing international collaboration, and a steady rise in publication volume within the field of AD. These findings highlight the continued need for clinical and biomarker-focused investigations to advance therapeutic development in AD.
Authors
- Anas A. Ahmed (ORCID: https://orcid.org/0000-0002-7736-1838)
- Gassem Gohal (ORCID: https://orcid.org/0000-0003-4956-8222)
- Yasir Babiker (ORCID: https://orcid.org/0000-0001-5628-5656)
- Osama Albasheer (ORCID: https://orcid.org/0000-0002-5115-6182)
- Abdullah Farasani (ORCID: https://orcid.org/0000-0001-6942-5136)
- Shahzad Ali (ORCID: https://orcid.org/0000-0003-4281-2659)
- Omar Oraibi (ORCID: https://orcid.org/0000-0003-4621-1113)
- Bassem Oraibi (ORCID: https://orcid.org/0000-0001-9207-9411)
- Ieman A. Aljahdali
- Manal Mohamed Elhassan Taha (ORCID: https://orcid.org/0000-0003-0166-8929)
- Siddig Ibrahim Abdelwahab
- Hassan Ahmad Alfaifi
- Ahmed Ali Jerah
- Amal Hamdan Alzahrani
Institutions
- Taif University (SA)
- King Abdulaziz University (SA)
- University of Jeddah (SA)
- Ministry of Health (SA)
- Jazan University (SA)
Publication Details
- Journal
- CNS & Neurological Disorders - Drug Targets
- Published
- 2025-05-20
- DOI
- https://doi.org/10.2174/0118715273349645250324040257
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00